Resources for You
FDA Basics Videos: Tim Coté on Orphan Drugs
Dr. Tim Coté is director of the FDA’s Office of Orphan Products Development. Coté's office is responsible for implementing the 1983 Orphan Drug Act, originally the brainchild of a Connecticut woman whose children suffered from a rare disease. In the years since that Act was passed, says Coté, 357 new therapies have gone to full marketing approval and another 2,100 compounds that are "promising" have been labeled as orphan drugs. The Office of Orphan Product Development also serves as an ombudsman for everyone from patients groups to industry, expediting the development of drugs to fight approximately 7,000 rare diseases, including Gaucher's, Pompe's, Muscular Dystrophy, and Cystic Fibrosis -- diseases that affect roughly 30 million Americans. But while Coté sees progress in the battle against rare diseases, he adds:"Things can't expand fast enough for the people who really need [orphan drugs].... The single most important thing is that we have to hurry because people have children who need therapies right now."
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- How FDA Evaluates Regulated Products: Drugs
- FDA Webinar on Prescription Drug Shortages
- FDA Webinar on "Bad Ads" Program
- FDA Basics Webinar on Generic Drugs
- FDA Basics Videos: Tim Coté on Orphan Drugs
- What is an FDA Drug Safety Communication?
- What is counterfeit medicine?
- FDA Basic Video: Interview with John Jenkins on New Drugs (Video)
- What are unapproved drugs and why are they on the market?
- How can I stay better informed about drugs? Is there a reliable website FDA recommends?
- How do I discard medicine that I no longer need, do I just throw it in the garbage?
- How do I report a bad reaction to medicine or medication error to FDA?
- Does FDA approve the proprietary names of prescription drugs?
- What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
- How does FDA help consumers when drug shortages happen?
- Does FDA approve the information given out by pharmacies when I pick up my medicine?
- How does FDA decide when a drug is not safe enough to stay on the market?
- How do I find out if a drug is approved? Is there a Web site I can go to?
- What is the approval process for a new prescription drug?
- What is a Warning Letter?
- Can FDA ban direct-to-consumer drug advertising?
How helpful was this information?